Navigation Links
Scientists capture most detailed picture yet of key AIDS protein
Date:10/31/2013

of two imaging methods, X-ray crystallography and electron microscopy. The X-ray crystallography study was the first ever of an Env trimer, and both methods resolved the trimer structure to a finer level of detail than has been reported before.

"The new data are consistent with the findings on Env subunits over the last 15 years, but also have enabled us to explain many prior observations about HIV in structural terms for the first time," said Dr. Jean-Philippe Julien, a senior research associate in the Wilson laboratory at TSRI, who was first author of the X-ray crystallography study.

The data illuminated the complex process by which the Env trimer assembles and later undergoes radical shape changes during infection and clarified how it compares to envelope proteins on other dangerous viruses, such as flu and Ebola.

Arguably the most important implications of the new findings are for HIV vaccine design. In both of the new studies, Env trimers were imaged while bound to broadly neutralizing antibodies against HIV. Such antibodies, isolated from naturally infected patients, are the very rare ones that somehow bind to Env in a way that blocks the infectivity of a high proportion of HIV strains.

Ideally an HIV vaccine would elicit large numbers of such antibodies from patients, and to achieve that, vaccine designers would like to know the precise structural details of the sites where these antibodies bind to the virus--so that they can mimic those viral "epitopes" with the vaccine.

"It's been a privilege for us to work with the Scripps' team on this project," said Dr. Moore, a professor of microbiology and immunology at Weill Cornell. "Now we all need to harness this new knowledge to design and test next-generation trimers and see if we can induce the broadly active neutralizing antibodies that an effective vaccine is going to need."

"One surprise from this study was the revelation of the complexity and the relati
'/>"/>

Contact: Sarah Smith
sas2072@med.cornell.edu
646-317-7401
Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. NIH-funded scientists reveal structure of HIV protein key to cell entry
2. Scientists discover why newborns get sick so often
3. Scientists modify Botox for the treatment of pain
4. UNC neuroscientists discover new mini-neural computer in the brain
5. New Genetic Error in Some Lung Cancers Identified by CU Scientists
6. CNIO scientists reduce progression of one of the most aggressive skin cancers in mice
7. Chicago Public High School Students to Rub Shoulders with Scientists from Around the World
8. NIH scientists pursue new therapies to improve rare disease drug development
9. NCI scientists identify targets for melanoma immunotherapy
10. Peering into Genetic Defects, CU Scientists Discover a New Metabolic Disease
11. What scientists can see in your pee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and ... will expedite the delivery of laboratory samples and ... districts of the Northern and Central Zones of ... for Health will establish a dependable and coordinated ... critical bottleneck in health services for the more ...
(Date:7/31/2014)... View, Calif. and Las Vegas, Nevada (PRWEB) July 31, ... partnership with LaunchKey to provide next generation authentication services ... simple and secure way to utilize hardware protected multi-factor ... enormous problem in the Internet's reliance on password-based authentication. ... hacks and global data breaches taking place around the ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... to reach USD 37.83 billion by 2020, according ... Inc. Increasing geriatric population base augmenting the susceptibility ... orthopedic, and respiratory diseases coupled with increasing patient ... over the next six years. Some of the ...
(Date:7/31/2014)... 31, 2014 (HealthDay News) -- Recovery time after surgery ... known as statins, according to a new study. ... affect the body,s inflammatory response, reducing the amount of ... seemed to be particularly true among people who tend ... of the most widely prescribed medications in the world. ...
(Date:7/31/2014)... 2014 A new catheter being ... helping patients who have an abnormal heart rhythm. ... ablation procedures for patients such as those suffering ... Baptist Heart Specialists were the first in north ... past spring, according to Biosense Webster, which develops ...
Breaking Medicine News(10 mins):Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Cholesterol Drugs May Speed Healing After Surgery 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3
... near the World Trade Center had sleeplessness, other problems, ... Direct exposure to the World Trade Center terrorist ... , The study, by researchers at the Mount Sinai ... children averaging about 4 years of age who lived ...
... Merrill Lynch,s Global Pharmaceutical Conference Feb. ... 5, 2008, ... it will host a conference call and live webcast on,Wednesday, Feb. 27, 2008, ... ended Dec. 31, 2007. The Company also will provide,an operational and integration update ...
... CLARA, Calif., Feb. 5 Coherent, Inc.,(Pink Sheets: COHR), ... included in the company,s proxy for the annual meeting ... subject to election by,shareholders. The nominees include current directors ... Vij as well as first-time,nominees Susan James and Clifford ...
... Engineering,Group Inc. (NYSE: JEC ) announced today that ... in managing the Sequoia Hospital Program,in Redwood City, Calif. ... including a new 104-bed tower, a retrofit of 63 ... a parking structure. The,overall project is expected to be ...
... VIEW, Calif., Feb. 5 MAP,Pharmaceuticals, Inc. (Nasdaq: ... B. Shrewsbury, M.B., Ch.B., Chief Medical,Officer, will be leaving ... Shrewsbury plans to provide consulting services to the company,for ... want to thank Steve for his many contributions and ...
... Feb. 5 Favrille, Inc. (Nasdaq:,FVRL), a biopharmaceutical ... cancer, announced today that it will,host a conference ... Time on,Tuesday, February 19, 2008 to discuss the ... A press release will be issued before the ...
Cached Medicine News:Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007 2Health News:Coherent Announces Director Slate for Upcoming Annual Meeting 2Health News:Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program 2Health News:MAP Pharmaceuticals Announces Resignation of Chief Medical Officer 2Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
(Date:7/31/2014)... , July 31, 2014 Astellas ... head of corporate and employee communications in the ... Jeff Winton , senior vice president, chief communications ... for developing and leading corporate brand initiatives and ... across North and South America ...
(Date:7/31/2014)... -- Cryoport, Inc. (OTCBB: CYRX) today announced financial results ... Recent Operating Highlights , Achieved ... month period ended June 30, 2014 compared to the ... further expand Cryoport,s global reach using the ,powered by ... Immudex, an immunotherapy and vaccine development services company, to ...
(Date:7/31/2014)... 2014 Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" ... premium branded consumer products, including commercially cultivated Cordyceps Militaris ... announced the signing of its first distributor for its ... Hubei Province located ... . The contract with the ...
Breaking Medicine Technology:Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
PremierEdge Stab Knives - 30....
... for the total eye. Whether used ... mode or set independently to accommodate ... settings are adjustable to accommodate maximizing ... for use with tonometer-mounted, hand-held and ...
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: